BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harper A, Vijayakumar V, Ouwehand AC, Ter Haar J, Obis D, Espadaler J, Binda S, Desiraju S, Day R. Viral Infections, the Microbiome, and Probiotics. Front Cell Infect Microbiol 2020;10:596166. [PMID: 33643929 DOI: 10.3389/fcimb.2020.596166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao T, Verma HK, Pande B, Costanzo V, Ye W, Cai Y, Bhaskar LVKS. Physical Activity and Nutritional Influence on Immune Function: An Important Strategy to Improve Immunity and Health Status. Front Physiol 2021;12:751374. [PMID: 34690818 DOI: 10.3389/fphys.2021.751374] [Reference Citation Analysis]
2 Howard F, Conner J, Danson S, Muthana M. Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability. Front Mol Biosci 2022;9:889395. [DOI: 10.3389/fmolb.2022.889395] [Reference Citation Analysis]
3 Reyes-castillo PA, González-vázquez R, Torres-maravilla E, Tello M, Bermúdez-humarán LG, Mayorga-reyes L. Probiotics against Viral Infections: Current Clinical Trials and Future Perspectives. Immuno 2021;1:468-98. [DOI: 10.3390/immuno1040034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Llor C, Ouchi D, Giner-Soriano M, García-Sangenís A, Bjerrum L, Morros R. Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study. Antibiotics (Basel) 2021;10:1364. [PMID: 34827302 DOI: 10.3390/antibiotics10111364] [Reference Citation Analysis]
5 Sachdeva M, Sra HK, Agarwal A, Chauhan A, Pradhan P, Singh M, Singh M. Effect of Probiotics on the Frequency of CD4+ T-Cells in HIV-Infected Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Trop Pediatr 2022;68:fmac006. [PMID: 35137236 DOI: 10.1093/tropej/fmac006] [Reference Citation Analysis]
6 Chen L, Guo X, Wang L, Geng J, Wu J, Hu B, Wang T, Li J, Liu C, Wang H. In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS. Drug Deliv 2021;28:1637-48. [PMID: 34338123 DOI: 10.1080/10717544.2021.1960922] [Reference Citation Analysis]
7 Morse ZJ, Horwitz MS. Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes. Front Immunol 2021;12:751337. [PMID: 34721424 DOI: 10.3389/fimmu.2021.751337] [Reference Citation Analysis]
8 Cortes GM, Marcialis MA, Bardanzellu F, Corrias A, Fanos V, Mussap M. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Front Microbiol 2022;13:856165. [PMID: 35391730 DOI: 10.3389/fmicb.2022.856165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Koenen MH, de Steenhuijsen Piters WAA, Bogaert D, Verhagen LM. The microbiota in respiratory tract infections: from association to intervention. Curr Opin Infect Dis 2022;35:215-22. [PMID: 35665715 DOI: 10.1097/QCO.0000000000000826] [Reference Citation Analysis]
10 Ribeiro AI, Dias AM, Zille A. Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review. ACS Appl Nano Mater 2022;5:3030-64. [DOI: 10.1021/acsanm.1c03891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
11 Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, Costa Antunes AE. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022;120:174-92. [PMID: 35002079 DOI: 10.1016/j.tifs.2021.12.033] [Reference Citation Analysis]
12 Batista KS, de Albuquerque JG, Vasconcelos MHA, Bezerra MLR, da Silva Barbalho MB, Pinheiro RO, Aquino JS. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19? Nutr Res Rev 2021;:1-18. [PMID: 34668465 DOI: 10.1017/S0954422421000317] [Reference Citation Analysis]
13 Konturek PC. [How does COVID-19 affect intestinal microbiota?]. MMW Fortschr Med 2021;163:17-20. [PMID: 34383283 DOI: 10.1007/s15006-021-0200-5] [Reference Citation Analysis]
14 Suskun C, Kilic O, Yilmaz Ciftdogan D, Guven S, Karbuz A, Ozkaya Parlakay A, Kara Y, Kacmaz E, Sahin A, Boga A, Kizmaz Isancli D, Gulhan B, Yuksek SK, Kiral E, Bozan G, Arslanoglu MO, Kizil MC, Dinleyici M, Us T, Varis A, Kaya M, Vandenplas Y, Dinleyici EC. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C). Eur J Pediatr 2022. [PMID: 35585256 DOI: 10.1007/s00431-022-04494-9] [Reference Citation Analysis]
15 Pandey M, Bhati A, Priya K, Sharma KK, Singhal B. Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications. Probiotics Antimicrob Proteins 2021. [PMID: 34806151 DOI: 10.1007/s12602-021-09875-4] [Reference Citation Analysis]